There are several well known risk factors for osteoporosis including age, sex, low body weight and low bone mineral density. But did you know that other less well known risk […]

OUR PARTNERS Thank you to our partners, whose vital support allows Osteoporosis Canada to continue to be at the forefront of osteoporosis support, education, research and advocacy for all Canadians. […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

FRAX In addition to femoral neck (hip) BMD, age, gender, fracture history and steroid use, FRAX also takes into account other clinical risk factors to calculate the absolute 10-year risk […]

SECONDARY OSTEOPOROSIS Medications and medical conditions can increase the risk of osteoporosis and osteoporotic fractures. Drugs and Diseases that can Cause Bone Loss, Falls and/or Fractures There are several well […]

On September 29, 2015, two research articles were published online in the British Medical Journal (BMJ) concerning the effect of calcium intake on bone mineral density (BMD) and fracture reduction. […]

CAROC In 2005, Osteoporosis Canada, in association with the Canadian Association of Radiologists, launched the 10-year absolute fracture risk assessment – CAROC. In addition to BMD (lowest T-score of hip […]

Bisphosphonate therapy – long term use Recently a study published by Drieling et al in JAGS 2017 described the results of a cohort study of 5120 older women with an […]

The recent study by Bolland and colleagues published in the Lancet Diabetes Endocrinology (Oct 4, 2018) is an updated meta-analysis that evaluated the effects of vitamin D supplementation on fractures, […]